Management of Anemia in Advanced Breast and Lung Cancer Patients in Daily Practice: Results of a French Survey

@article{RayCoquard2012ManagementOA,
  title={Management of Anemia in Advanced Breast and Lung Cancer Patients in Daily Practice: Results of a French Survey},
  author={Isabelle Ray-Coquard and Jean-François Mor{\`e}re and Florian Scott{\'e} and Laurent Cals and E. Ch. Antoine},
  journal={Advances in Therapy},
  year={2012},
  volume={29},
  pages={124-133}
}
IntroductionThe purpose of this French survey was to evaluate the adherence to the guidelines (European Organisation for Research and Treatment of Cancer [EORTC]; American Society of Clinical Oncology [ASCO]; French Standards, Options, and Recommendations [SOR]; European Society of Medical Oncology [ESMO]; Food and Drug Administration [FDA]; and National Comprehensive Cancer Network [NCCN]) for the use of erythropoiesis-stimulating agents (ESAs) in the management of chemotherapy-induced anemia… CONTINUE READING
2
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 17 REFERENCES

in Oncology

NCCN Practice Guideline
  • Cancerrelated fatigue. V.I.2010. Available at: www.nccn. org. Accessed December 22,
  • 2011
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Erythropoiesis-stimulating agents in cancer patients: ESMO recommendations for use.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2009
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Erythropoietin, the FDA, and oncology.

  • The New England journal of medicine
  • 2007
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL